An Open-Label Adaptive Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Efficacy of Multiple Doses of Radiprodil in Subjects With Drug-Resistant Infantile Spasms
Phase of Trial: Phase I/II
Latest Information Update: 19 Apr 2018
At a glance
- Drugs Radiprodil (Primary)
- Indications Infantile spasms
- Focus Adverse reactions; Therapeutic Use
- Sponsors UCB
- 09 Apr 2018 Planned End Date changed from 11 Nov 2020 to 19 Mar 2021.
- 09 Apr 2018 Planned primary completion date changed from 11 Nov 2020 to 19 Mar 2021.
- 05 Feb 2018 Planned End Date changed from 1 Jan 2020 to 11 Nov 2020.